Toward modernizing the systematic review pipeline in genetics: efficient updating via data mining.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMC 3908550)

Published in Genet Med on July 01, 2012

Authors

Byron C Wallace1, Kevin Small, Carla E Brodley, Joseph Lau, Christopher H Schmid, Lars Bertram, Christina M Lill, Joshua T Cohen, Thomas A Trikalinos

Author Affiliations

1: Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA. byron.wallace@gmail.com

Articles cited by this

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet (2007) 12.13

Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med (2001) 7.94

Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet (2008) 6.71

Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? PLoS Med (2010) 5.80

Identification of randomized controlled trials in systematic reviews: accuracy and reliability of screening records. Stat Med (2002) 5.35

A navigator for human genome epidemiology. Nat Genet (2008) 5.07

Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet (2012) 4.27

AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program. J Clin Epidemiol (2010) 2.63

Designing studies to ensure that estimates of test accuracy are transferable. BMJ (2002) 2.36

Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. Am J Epidemiol (2006) 2.34

Semi-automated screening of biomedical citations for systematic reviews. BMC Bioinformatics (2010) 2.00

GAPscreener: an automatic tool for screening human genetic association literature in PubMed using the support vector machine technique. BMC Bioinformatics (2008) 1.75

AHRQ series paper 3: identifying, selecting, and refining topics for comparative effectiveness systematic reviews: AHRQ and the effective health-care program. J Clin Epidemiol (2009) 1.73

Estimating time to conduct a meta-analysis from number of citations retrieved. JAMA (1999) 1.61

AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program. J Clin Epidemiol (2008) 1.57

Updating systematic reviews: an international survey. PLoS One (2010) 1.41

Using the principles of randomized controlled trial design to guide test evaluation. Med Decis Making (2009) 1.40

Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program. J Clin Epidemiol (2011) 1.24

AHRQ series paper 2: principles for developing guidance: AHRQ and the effective health-care program. J Clin Epidemiol (2009) 1.20

AHRQ series paper 1: comparing medical interventions: AHRQ and the effective health-care program. J Clin Epidemiol (2008) 1.15

Appropriate statistical methods are required to assess diagnostic tests for replacement, add-on, and triage. J Clin Epidemiol (2010) 1.15

Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations. Med Decis Making (2009) 1.07

Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age. Bone (2009) 0.93

Online genetic databases informing human genome epidemiology. BMC Med Res Methodol (2007) 0.91

Finding evidence for comparing medical interventions: AHRQ and the Effective Health Care Program. J Clin Epidemiol (2011) 0.89

Articles by these authors

A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04

Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99

Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care (2002) 10.00

Breastfeeding and maternal and infant health outcomes in developed countries. Evid Rep Technol Assess (Full Rep) (2007) 9.32

The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab (2007) 8.91

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell (2005) 8.40

The case of the misleading funnel plot. BMJ (2006) 8.26

Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol (2006) 7.66

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80

Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet (2008) 6.71

Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA (2007) 6.40

Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00

Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90

Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA (2002) 5.81

The volumetric analysis of fat graft survival in breast reconstruction. Plast Reconstr Surg (2013) 5.59

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med (2003) 5.47

n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr (2006) 5.43

Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med (2010) 5.36

'Racial' differences in genetic effects for complex diseases. Nat Genet (2004) 5.15

Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06

The genetics of Alzheimer disease: back to the future. Neuron (2010) 4.91

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62

The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med (2015) 4.49

A randomized trial of tai chi for fibromyalgia. N Engl J Med (2010) 4.37

Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis (2009) 4.30

Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet (2012) 4.27

Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials. J Clin Epidemiol (2005) 4.14

Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87

The effect of Tai Chi on health outcomes in patients with chronic conditions: a systematic review. Arch Intern Med (2004) 3.84

An exploratory test for an excess of significant findings. Clin Trials (2007) 3.83

Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med (2015) 3.75

Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med (2011) 3.71

Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold. N Engl J Med (2014) 3.57

Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus. Ann Intern Med (2006) 3.56

Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess (Full Rep) (2009) 3.51

Why clinicians are natural bayesians. BMJ (2005) 3.41

Genetic associations in large versus small studies: an empirical assessment. Lancet (2003) 3.41

The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ (2007) 3.40

Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol (2004) 3.28

Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care (2007) 3.27

Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol (2004) 3.24

Genetic test evaluation: information needs of clinicians, policy makers, and the public. Am J Epidemiol (2002) 3.23

Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS (2007) 3.22

Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med (2006) 3.17

National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics (2003) 3.10

Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet (2003) 3.00

Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol (2009) 2.92

Loss to analysis in randomized controlled trials in CKD. Am J Kidney Dis (2011) 2.85

An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics (2004) 2.80

Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers Dement (2010) 2.79

In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol (2005) 2.77

Statins, low-density lipoprotein cholesterol, and risk of cancer. J Am Coll Cardiol (2008) 2.77

The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev (2004) 2.73

Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med (2004) 2.67

Maternal obesity and risk of stillbirth: a metaanalysis. Am J Obstet Gynecol (2007) 2.66

Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med (2004) 2.64

Tai Chi is effective in treating knee osteoarthritis: a randomized controlled trial. Arthritis Rheum (2009) 2.63

Clinical practice guidelines in nephrology--for worse or for better. Nephrol Dial Transplant (2006) 2.58

Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis (2006) 2.56

Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol (2002) 2.56

Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA (2008) 2.52

Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med (2002) 2.49

Adjusting for publication bias in the presence of heterogeneity. Stat Med (2003) 2.42

Graft use in transvaginal pelvic organ prolapse repair: a systematic review. Obstet Gynecol (2008) 2.31

Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician (2004) 2.27

A quantitative analysis of fish consumption and coronary heart disease mortality. Am J Prev Med (2005) 2.27

Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescents. Circulation (2012) 2.24

Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care (2007) 2.20

Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis (2008) 2.19

Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology (2012) 2.18

Local literature bias in genetic epidemiology: an empirical evaluation of the Chinese literature. PLoS Med (2005) 2.18

Systematic review: charged-particle radiation therapy for cancer. Ann Intern Med (2009) 2.15

Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol (2009) 2.15

The lack of evidence for PET or PET/CT surveillance of patients with treated lymphoma, colorectal cancer, and head and neck cancer: a systematic review. J Nucl Med (2013) 2.14

Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis. PLoS One (2010) 2.10

Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA (2003) 2.10

A summary of the Agency for Healthcare Research and Quality's evidence report on breastfeeding in developed countries. Breastfeed Med (2009) 2.09

Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch Intern Med (2007) 2.09

Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: a meta-analysis. Am J Med (2004) 2.07

Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review. J Clin Oncol (2009) 2.05